Chlorine in PDB 1q4l: Gsk-3 Beta Complexed with Inhibitor I-5
Enzymatic activity of Gsk-3 Beta Complexed with Inhibitor I-5
All present enzymatic activity of Gsk-3 Beta Complexed with Inhibitor I-5:
2.7.1.37;
Protein crystallography data
The structure of Gsk-3 Beta Complexed with Inhibitor I-5, PDB code: 1q4l
was solved by
J.A.Bertrand,
S.Thieffine,
A.Vulpetti,
C.Cristiani,
B.Valsasina,
S.Knapp,
H.M.Kalisz,
M.Flocco,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
20.00 /
2.77
|
Space group
|
P 21 21 21
|
Cell size a, b, c (Å), α, β, γ (°)
|
84.167,
86.664,
178.650,
90.00,
90.00,
90.00
|
R / Rfree (%)
|
n/a /
n/a
|
Chlorine Binding Sites:
The binding sites of Chlorine atom in the Gsk-3 Beta Complexed with Inhibitor I-5
(pdb code 1q4l). This binding sites where shown within
5.0 Angstroms radius around Chlorine atom.
In total 4 binding sites of Chlorine where determined in the
Gsk-3 Beta Complexed with Inhibitor I-5, PDB code: 1q4l:
Jump to Chlorine binding site number:
1;
2;
3;
4;
Chlorine binding site 1 out
of 4 in 1q4l
Go back to
Chlorine Binding Sites List in 1q4l
Chlorine binding site 1 out
of 4 in the Gsk-3 Beta Complexed with Inhibitor I-5
 Mono view
 Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 1 of Gsk-3 Beta Complexed with Inhibitor I-5 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cl451
b:47.2
occ:1.00
|
CL7
|
A:679451
|
0.0
|
47.2
|
1.0
|
C4
|
A:679451
|
1.7
|
47.2
|
1.0
|
C5
|
A:679451
|
2.7
|
47.2
|
1.0
|
C3
|
A:679451
|
2.7
|
47.2
|
1.0
|
CD
|
A:LYS85
|
3.4
|
40.8
|
1.0
|
OD1
|
A:ASP200
|
3.4
|
65.5
|
1.0
|
CE
|
A:LYS85
|
3.5
|
40.2
|
1.0
|
NZ
|
A:LYS85
|
3.5
|
42.1
|
1.0
|
CG
|
A:ASP200
|
3.5
|
64.3
|
1.0
|
CA
|
A:GLY65
|
3.6
|
59.1
|
1.0
|
OD2
|
A:ASP200
|
3.9
|
65.7
|
1.0
|
CB
|
A:ASP200
|
4.0
|
55.9
|
1.0
|
CG2
|
A:VAL70
|
4.0
|
25.6
|
1.0
|
CA
|
A:ASP200
|
4.0
|
34.5
|
1.0
|
C2
|
A:679451
|
4.0
|
47.2
|
1.0
|
C6
|
A:679451
|
4.0
|
47.2
|
1.0
|
CG
|
A:LYS85
|
4.1
|
38.4
|
1.0
|
N
|
A:SER66
|
4.2
|
58.4
|
1.0
|
C
|
A:GLY65
|
4.3
|
60.2
|
1.0
|
C1
|
A:679451
|
4.5
|
47.2
|
1.0
|
N
|
A:ASP200
|
4.5
|
33.9
|
1.0
|
CB
|
A:LYS85
|
4.8
|
38.3
|
1.0
|
N
|
A:GLY65
|
4.9
|
57.9
|
1.0
|
|
Chlorine binding site 2 out
of 4 in 1q4l
Go back to
Chlorine Binding Sites List in 1q4l
Chlorine binding site 2 out
of 4 in the Gsk-3 Beta Complexed with Inhibitor I-5
 Mono view
 Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 2 of Gsk-3 Beta Complexed with Inhibitor I-5 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cl451
b:47.2
occ:1.00
|
CL2
|
A:679451
|
0.0
|
47.2
|
1.0
|
C19
|
A:679451
|
1.7
|
47.2
|
1.0
|
C18
|
A:679451
|
2.6
|
47.2
|
1.0
|
C20
|
A:679451
|
2.8
|
47.2
|
1.0
|
C23
|
A:679451
|
3.2
|
47.2
|
1.0
|
CA
|
A:GLY63
|
3.4
|
50.0
|
1.0
|
O25
|
A:679451
|
3.4
|
47.2
|
1.0
|
N
|
A:ASN64
|
3.4
|
68.3
|
1.0
|
C
|
A:GLY63
|
3.6
|
53.4
|
1.0
|
O
|
A:ILE62
|
3.7
|
50.9
|
1.0
|
O
|
A:ASN64
|
3.7
|
73.6
|
1.0
|
C17
|
A:679451
|
3.9
|
47.2
|
1.0
|
O24
|
A:679451
|
4.0
|
47.2
|
1.0
|
NE2
|
A:GLN185
|
4.0
|
47.7
|
1.0
|
C21
|
A:679451
|
4.1
|
47.2
|
1.0
|
N
|
A:GLY63
|
4.3
|
46.6
|
1.0
|
C
|
A:ASN64
|
4.3
|
73.0
|
1.0
|
C
|
A:ILE62
|
4.3
|
51.2
|
1.0
|
CA
|
A:ASN64
|
4.4
|
71.5
|
1.0
|
O
|
A:GLY63
|
4.4
|
53.0
|
1.0
|
C16
|
A:679451
|
4.5
|
47.2
|
1.0
|
|
Chlorine binding site 3 out
of 4 in 1q4l
Go back to
Chlorine Binding Sites List in 1q4l
Chlorine binding site 3 out
of 4 in the Gsk-3 Beta Complexed with Inhibitor I-5
 Mono view
 Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 3 of Gsk-3 Beta Complexed with Inhibitor I-5 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Cl452
b:43.3
occ:1.00
|
CL7
|
B:679452
|
0.0
|
43.3
|
1.0
|
C4
|
B:679452
|
1.7
|
43.3
|
1.0
|
C5
|
B:679452
|
2.7
|
43.3
|
1.0
|
C3
|
B:679452
|
2.7
|
43.3
|
1.0
|
CD
|
B:LYS85
|
3.3
|
48.8
|
1.0
|
NZ
|
B:LYS85
|
3.4
|
52.2
|
1.0
|
OD1
|
B:ASP200
|
3.4
|
44.2
|
1.0
|
CE
|
B:LYS85
|
3.5
|
51.1
|
1.0
|
CG
|
B:ASP200
|
3.6
|
43.5
|
1.0
|
CA
|
B:ASP200
|
4.0
|
33.3
|
1.0
|
CB
|
B:ASP200
|
4.0
|
38.9
|
1.0
|
C2
|
B:679452
|
4.1
|
43.3
|
1.0
|
OD2
|
B:ASP200
|
4.1
|
45.9
|
1.0
|
CG
|
B:LYS85
|
4.1
|
47.2
|
1.0
|
CG2
|
B:VAL70
|
4.1
|
32.9
|
1.0
|
C6
|
B:679452
|
4.1
|
43.3
|
1.0
|
CA
|
B:GLY65
|
4.1
|
56.4
|
1.0
|
O
|
B:HOH528
|
4.3
|
36.4
|
1.0
|
C
|
B:GLY65
|
4.6
|
56.5
|
1.0
|
CB
|
B:LYS85
|
4.6
|
46.0
|
1.0
|
N
|
B:ASP200
|
4.6
|
30.6
|
1.0
|
C1
|
B:679452
|
4.6
|
43.3
|
1.0
|
N
|
B:SER66
|
4.7
|
97.1
|
1.0
|
OE2
|
B:GLU97
|
4.7
|
65.2
|
1.0
|
|
Chlorine binding site 4 out
of 4 in 1q4l
Go back to
Chlorine Binding Sites List in 1q4l
Chlorine binding site 4 out
of 4 in the Gsk-3 Beta Complexed with Inhibitor I-5
 Mono view
 Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 4 of Gsk-3 Beta Complexed with Inhibitor I-5 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Cl452
b:43.3
occ:1.00
|
CL2
|
B:679452
|
0.0
|
43.3
|
1.0
|
C19
|
B:679452
|
1.7
|
43.3
|
1.0
|
C18
|
B:679452
|
2.6
|
43.3
|
1.0
|
C20
|
B:679452
|
2.8
|
43.3
|
1.0
|
N
|
B:ASN64
|
2.9
|
82.2
|
1.0
|
C23
|
B:679452
|
3.1
|
43.3
|
1.0
|
O25
|
B:679452
|
3.2
|
43.3
|
1.0
|
CA
|
B:GLY63
|
3.2
|
36.4
|
1.0
|
C
|
B:GLY63
|
3.6
|
38.2
|
1.0
|
O
|
B:ASN64
|
3.7
|
85.8
|
1.0
|
O
|
B:ILE62
|
3.9
|
70.1
|
1.0
|
NE2
|
B:GLN185
|
3.9
|
65.6
|
1.0
|
C17
|
B:679452
|
3.9
|
43.3
|
1.0
|
O24
|
B:679452
|
4.0
|
43.3
|
1.0
|
CA
|
B:ASN64
|
4.0
|
84.7
|
1.0
|
C21
|
B:679452
|
4.0
|
43.3
|
1.0
|
C
|
B:ASN64
|
4.2
|
85.3
|
1.0
|
N
|
B:GLY63
|
4.4
|
33.9
|
1.0
|
C16
|
B:679452
|
4.5
|
43.3
|
1.0
|
C
|
B:ILE62
|
4.6
|
69.4
|
1.0
|
CB
|
B:ASN64
|
4.7
|
57.4
|
1.0
|
O
|
B:GLY63
|
4.8
|
37.7
|
1.0
|
|
Reference:
J.A.Bertrand,
S.Thieffine,
A.Vulpetti,
C.Cristiani,
B.Valsasina,
S.Knapp,
H.M.Kalisz,
M.Flocco.
Structural Characterization of the Gsk-3BETA Active Site Using Selective and Non-Selective Atp-Mimetic Inhibitors J.Mol.Biol. V. 333 393 2003.
ISSN: ISSN 0022-2836
PubMed: 14529625
DOI: 10.1016/J.JMB.2003.08.031
Page generated: Sat Jul 20 01:22:41 2024
|